Abstract
Identifying differentially expressed genes from RNA sequencing data remains a challenging task because of the considerable uncertainties in parameter estimation and the small sample sizes in typical applications. Here we introduce Bayesian Analysis of Differential Expression in RNA-sequencing data (BADER). Due to our choice of data and prior distributions, full posterior inference for BADER can be carried out efficiently. The method appropriately takes uncertainty in gene variance into account, leading to higher power than existing methods in detecting differentially expressed genes. Moreover, we show that the posterior samples can be naturally integrated into downstream gene set enrichment analyses, with excellent performance in detecting enriched sets. An open-source R package (BADER) that provides a user-friendly interface to a C++ back-end is available on Bioconductor.
Introduction
RNA-sequencing (RNA-seq) has revolutionized gene expression measurement, but the resulting data is inherently noisy. A primary challenge is overdispersion, where the variance between samples exceeds the mean due to biological variability. Most standard tools, such as edgeR or DESeq, employ frequentist statistical tests to identify differentially expressed (DE) genes. However, these methods often struggle with the small sample sizes (e.g., 2-3 replicates) common in biological research. They frequently fail to account for the full uncertainty in variance estimation, leading to false positives or missed discoveries. Furthermore, errors in uncertainty quantification at the gene level can propagate into downstream analyses like Gene Set Enrichment Analysis (GSEA), resulting in biased conclusions.
Methods
BADER (Bayesian Analysis of Differential Expression in RNA-sequencing data) addresses these issues through a robust hierarchical Bayesian framework.
The Poisson-Lognormal Model
Unlike traditional tools that rely on the Negative Binomial distribution, BADER utilizes a two-stage Poisson-lognormal model. This choice facilitates efficient Markov chain Monte Carlo (MCMC) sampling, as many parameters can be updated in closed form.
Information Sharing and Uncertainty
To mitigate the limitations of small sample sizes, BADER employs a "hyperprior" to share information across all genes, a process known as shrinkage. This helps stabilize variance estimates for individual genes. Crucially, BADER provides a full posterior distribution for parameters rather than a single point estimate. This allows the model to explicitly represent uncertainty; if data for a specific gene is noisy, the posterior reflects this higher uncertainty.
Probability of Differential Expression
BADER models the log-fold change as a mixture of a point mass at zero (no change) and a normal distribution (real change). This enables the calculation of an actual posterior probability that a gene is DE, offering a more intuitive metric than standard p-values.
Results
The authors evaluated BADER using human RNA-seq datasets (Pickrell et al., 2010; Katz et al., 2010) and extensive simulations.
Superior DE Detection
In comparative evaluations using Receiver Operating Characteristic (ROC) curves, BADER consistently outperformed industry standards including edgeR, DESeq, baySeq, and DSS. By better quantifying uncertainty, BADER achieves higher statistical power while maintaining control over false positives.
Enhanced Gene Set Enrichment Analysis
A key advantage of the Bayesian approach is the natural integration of posterior samples into downstream GSEA. BADER avoids the common bias where low-count genes are unfairly weighted, leading to significantly higher power to detect enriched gene sets compared to frequentist pipelines (e.g., DESeq followed by Fisher’s exact test).
Calibration and Efficiency
Validation on the Pickrell dataset confirmed that BADER’s 80% credible intervals are well-calibrated, containing the true parameter values 70-90% of the time even with only two replicates. The C++ implementation ensures computational efficiency, processing approximately 10,000 genes at 0.13 seconds per MCMC iteration.
Discussion and Limitations
While BADER offers superior uncertainty quantification, Bayesian MCMC is inherently more computationally intensive than frequentist alternatives, which may pose challenges for extremely large datasets. Currently, the framework is optimized for two-group comparisons; extending it to complex designs like time-series or multi-factor experiments is a priority for future development. Additionally, addressing isoform-level complexity—where estimates between different versions of the same gene are coupled—remains a significant statistical frontier.
Summary updated